What the research found
Researchers analysed reports submitted to a national adverse events database and found energy drinks and stimulant-containing supplements were associated with a markedly elevated frequency of severe cardiac events. The data showed these products appeared in reports of cardiac arrest at roughly 11-fold higher rates and heart attacks at 4.5-fold higher rates compared to baseline. Notably, people under 40 made up close to half of all cardiovascular incidents linked to these products, which is striking given that serious heart events are relatively uncommon in younger populations.
The study worked with reported adverse events rather than controlled trials, meaning the researchers identified patterns in existing complaint data rather than measuring direct cause-and-effect in a study population.
Why it matters for you
If you're using stimulants—whether as dedicated energy drinks, pre-workout supplements, or standalone products like caffeine pills—this signals real risk, particularly if you're younger. The concentration of events in under-40s suggests age alone doesn't protect you from cardiac strain, contrary to assumptions some people hold.
Consider cross-referencing your supplement stack against ingredients. High caffeine doses, especially combined with other sympathomimetics (phenylephrine, synephrine, etc.), create cumulative stimulant load that stresses your heart. If you track heart rate variability or resting heart rate in MyKine, elevated baseline values or reduced HRV might indicate your nervous system is running hot. Similarly, if you're monitoring blood pressure, lipids, or electrolytes—all relevant to cardiac function—stimulant overuse can degrade these markers.
The risk isn't zero at any age, but the data here suggest younger users may be overestimating their cardiovascular resilience.
Caveats
- Adverse event reports ≠ causation: The database captures what people report, not proof the product caused the event. Confounding factors (other drugs, underlying conditions, dosing) aren't controlled.
- Reporting bias: Serious events are more likely to be reported than minor ones; mild problems may be underrepresented.
- No denominator data: The study doesn't say how many people actually consume these products, so absolute risk remains unclear.
- Product heterogeneity: "Energy drinks and stimulant supplements" is broad; risk likely varies widely by formulation and dose.